3-Epi-25-hydroxyvitamin D

Calcifediol / blood Fetal Blood / metabolism Humans Protein Binding Recombinant Proteins / metabolism Sulfates / metabolism Sulfotransferases / metabolism
3-Epi-25-hydroxyvitamin D(3) Cord plasma SULT2A1 Substrate specificity Sulfation

Journal

Steroids
ISSN: 1878-5867
Titre abrégé: Steroids
Pays: United States
ID NLM: 0404536

Informations de publication

Date de publication:
10 2020
Historique:
received: 29 05 2020
revised: 25 06 2020
accepted: 30 06 2020
pubmed: 11 7 2020
medline: 16 6 2021
entrez: 11 7 2020
Statut: ppublish

Résumé

A variety of metabolites derived from 25-hydroxyvitamin D

Identifiants

DOI: 10.1016/j.steroids.2020.108695 PMID: 32649998
pubmed: 32649998
pii: S0039-128X(20)30121-5
doi: 10.1016/j.steroids.2020.108695
pii:
doi:

Substances chimiques

Recombinant Proteins 0
Sulfates 0
Sulfotransferases EC 2.8.2.-
alcohol sulfotransferase EC 2.8.2.2
Calcifediol P6YZ13C99Q

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108695

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yusuke Yoshimura (Y)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-8510, Japan.

Moeka Togashi (M)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-8510, Japan.

Shoujiro Ogawa (S)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-8510, Japan; Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama-shi, Hiroshima 729-0292, Japan.

Tatsuya Higashi (T)

Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-8510, Japan. Electronic address: higashi@rs.tus.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Lipides › Lipides membranaires › Stérols › Cholécalciférol › Hydroxycholécalciférols › Calcifédiol › 3-Epi-25-hydroxyvitamin D
questionsmedicales.fr › Structures de l'embryon › Foetus › Sang foetal › 3-Epi-25-hydroxyvitamin D
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › 3-Epi-25-hydroxyvitamin D
questionsmedicales.fr › Métabolisme › Liaison aux protéines › 3-Epi-25-hydroxyvitamin D
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines recombinantes › 3-Epi-25-hydroxyvitamin D
questionsmedicales.fr › Produits chimiques inorganiques › Sulfates › 3-Epi-25-hydroxyvitamin D
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Transferases › Sulfur group transferases › Sulfotransferases › 3-Epi-25-hydroxyvitamin D